We are proud to announce the launch of the website for LEOPARD: Liver Electronic Offering Platform with ARtificial Intelligence-based Devices.
The LEOPARD project stands as a pioneering effort in the field of liver transplantation (LT), uniting stakeholders across Europe to revolutionise organ allocation strategies for individuals with decompensated cirrhosis (DC) and hepatocellular carcinoma (HCC) through the use of AI-based predictive algorithms.
The website offers comprehensive insights into the mission and objectives of LEOPARD, as well as the latest news and updates on various research initiatives. Stay informed and engaged by following us on Linkedin (@leopard-eu) and X (@LEOPARD_EU), and track #LEOPARD_AI to see the key players steering the latest advancements.
“The funding of the LEOPARD project by the European Commission offers the first consortium of key European LT stakeholders. The consortium includes organ-sharing organisations (OSOs), including ABM, CNT, ONT, EuroTransplant, as well as 50 liver transplantation centres, major key opinion leaders in the field of hepatology, liver oncology, liver surgery and liver transplantation, statisticians, research labs, small and medium-sized enterprises (SMEs) and patient organisations.
The project will explore and prospectively validate advanced, second and next-generation predictive algorithms in liver transplant candidates which will be offered to participating OSOs to improve outcomes, reduce mortality on the waitlist, and harmonise offering schemes across Europe.” – Christophe Duvoux, LEOPARD project co-ordinator.
